# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000912282-07-000360
Filing Date
2007-03-30
Accepted
2007-03-29 18:43:48
Documents
92
Period of Report
2007-03-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | oncolytics6k_annualreport.htm | 6-K | 28739
2 | GRAPHIC | ar_1.jpg | GRAPHIC | 146345
3 | GRAPHIC | ar_10.jpg | GRAPHIC | 132256
4 | GRAPHIC | ar_11.jpg | GRAPHIC | 125337
5 | GRAPHIC | ar_12.jpg | GRAPHIC | 123814
6 | GRAPHIC | ar_13.jpg | GRAPHIC | 123717
7 | GRAPHIC | ar_14.jpg | GRAPHIC | 125724
8 | GRAPHIC | ar_15.jpg | GRAPHIC | 130798
9 | GRAPHIC | ar_16.jpg | GRAPHIC | 120772
10 | GRAPHIC | ar_17.jpg | GRAPHIC | 118839
11 | GRAPHIC | ar_18.jpg | GRAPHIC | 112087
12 | GRAPHIC | ar_19.jpg | GRAPHIC | 130745
13 | GRAPHIC | ar_2.jpg | GRAPHIC | 129850
14 | GRAPHIC | ar_20.jpg | GRAPHIC | 122315
15 | GRAPHIC | ar_21.jpg | GRAPHIC | 108218
16 | GRAPHIC | ar_22.jpg | GRAPHIC | 93369
17 | GRAPHIC | ar_23.jpg | GRAPHIC | 77272
18 | GRAPHIC | ar_24.jpg | GRAPHIC | 132873
19 | GRAPHIC | ar_25.jpg | GRAPHIC | 102998
20 | GRAPHIC | ar_26.jpg | GRAPHIC | 121265
21 | GRAPHIC | ar_27.jpg | GRAPHIC | 118220
22 | GRAPHIC | ar_28.jpg | GRAPHIC | 136147
23 | GRAPHIC | ar_29.jpg | GRAPHIC | 166027
24 | GRAPHIC | ar_3.jpg | GRAPHIC | 155362
25 | GRAPHIC | ar_30.jpg | GRAPHIC | 142459
26 | GRAPHIC | ar_31.jpg | GRAPHIC | 123546
27 | GRAPHIC | ar_32.jpg | GRAPHIC | 131578
28 | GRAPHIC | ar_33.jpg | GRAPHIC | 130812
29 | GRAPHIC | ar_34.jpg | GRAPHIC | 84396
30 | GRAPHIC | ar_35.jpg | GRAPHIC | 61904
31 | GRAPHIC | ar_36.jpg | GRAPHIC | 70725
32 | GRAPHIC | ar_37.jpg | GRAPHIC | 89781
33 | GRAPHIC | ar_38.jpg | GRAPHIC | 127779
34 | GRAPHIC | ar_39.jpg | GRAPHIC | 140521
35 | GRAPHIC | ar_4.jpg | GRAPHIC | 136496
36 | GRAPHIC | ar_40.jpg | GRAPHIC | 107819
37 | GRAPHIC | ar_41.jpg | GRAPHIC | 82759
38 | GRAPHIC | ar_42.jpg | GRAPHIC | 111634
39 | GRAPHIC | ar_43.jpg | GRAPHIC | 110209
40 | GRAPHIC | ar_44.jpg | GRAPHIC | 116001
41 | GRAPHIC | ar_45.jpg | GRAPHIC | 168012
42 | GRAPHIC | ar_46.jpg | GRAPHIC | 83675
43 | GRAPHIC | ar_47.jpg | GRAPHIC | 91890
44 | GRAPHIC | ar_48.jpg | GRAPHIC | 95728
45 | GRAPHIC | ar_49.jpg | GRAPHIC | 122471
46 | GRAPHIC | ar_5.jpg | GRAPHIC | 141650
47 | GRAPHIC | ar_50.jpg | GRAPHIC | 102834
48 | GRAPHIC | ar_51.jpg | GRAPHIC | 113794
49 | GRAPHIC | ar_52.jpg | GRAPHIC | 100982
50 | GRAPHIC | ar_53.jpg | GRAPHIC | 113046
51 | GRAPHIC | ar_54.jpg | GRAPHIC | 56964
52 | GRAPHIC | ar_55.jpg | GRAPHIC | 133620
53 | GRAPHIC | ar_56.jpg | GRAPHIC | 34329
54 | GRAPHIC | ar_6.jpg | GRAPHIC | 101268
55 | GRAPHIC | ar_7.jpg | GRAPHIC | 154534
56 | GRAPHIC | ar_8.jpg | GRAPHIC | 130557
57 | GRAPHIC | ar_9.jpg | GRAPHIC | 125839
58 | GRAPHIC | ballot.jpg | GRAPHIC | 751
59 | GRAPHIC | ballotx.jpg | GRAPHIC | 762
60 | GRAPHIC | cir_01.jpg | GRAPHIC | 21071
61 | GRAPHIC | cir_02.jpg | GRAPHIC | 85347
62 | GRAPHIC | cir_03.jpg | GRAPHIC | 92263
63 | GRAPHIC | cir_04.jpg | GRAPHIC | 8211
64 | GRAPHIC | cir_05.jpg | GRAPHIC | 114652
65 | GRAPHIC | cir_06.jpg | GRAPHIC | 136353
66 | GRAPHIC | cir_07.jpg | GRAPHIC | 126447
67 | GRAPHIC | cir_08.jpg | GRAPHIC | 73509
68 | GRAPHIC | cir_09.jpg | GRAPHIC | 95107
69 | GRAPHIC | cir_10.jpg | GRAPHIC | 109073
70 | GRAPHIC | cir_11.jpg | GRAPHIC | 55166
71 | GRAPHIC | cir_12.jpg | GRAPHIC | 135353
72 | GRAPHIC | cir_13.jpg | GRAPHIC | 112614
73 | GRAPHIC | cir_14.jpg | GRAPHIC | 91847
74 | GRAPHIC | cir_15.jpg | GRAPHIC | 73058
75 | GRAPHIC | cir_16.jpg | GRAPHIC | 84315
76 | GRAPHIC | cir_17.jpg | GRAPHIC | 87559
77 | GRAPHIC | cir_18.jpg | GRAPHIC | 104538
78 | GRAPHIC | cir_19.jpg | GRAPHIC | 70574
79 | GRAPHIC | cir_20.jpg | GRAPHIC | 73246
80 | GRAPHIC | cir_21.jpg | GRAPHIC | 140625
81 | GRAPHIC | cir_22.jpg | GRAPHIC | 93439
82 | GRAPHIC | cir_23.jpg | GRAPHIC | 60543
83 | GRAPHIC | cir_24.jpg | GRAPHIC | 115211
84 | GRAPHIC | cir_25.jpg | GRAPHIC | 80786
85 | GRAPHIC | cir_26.jpg | GRAPHIC | 77702
86 | GRAPHIC | cir_27.jpg | GRAPHIC | 79002
87 | GRAPHIC | cir_28.jpg | GRAPHIC | 71842
88 | GRAPHIC | img1.gif | GRAPHIC | 145
89 | GRAPHIC | img2.gif | GRAPHIC | 166
90 | GRAPHIC | img3.gif | GRAPHIC | 174
91 | GRAPHIC | sedar_1.jpg | GRAPHIC | 79266
92 | GRAPHIC | sedar_2.jpg | GRAPHIC | 63522
| Complete submission text file | 0000912282-07-000360.txt |  | 12591492

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 07728974
SIC: 2834 Pharmaceutical Preparations